All filters
Abstracts
COLDA_2020_abstract_47_Impact of Treating Hyperuricemic NAFLD Patients with Allopurinol on Cytokeratin 18: A Pilot Study
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_48_IL-23 and MMP-9 as predictors of adverse course of psoriasis and NAFLD comorbidities
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_49_Les hépatites auto-immunes à l’Hôpital Principal de Dakar : étude rétrospective à propos de 19 cas.
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_50_Hepatorenal Modulatory Effects of Ricinus Communis fractions in Acetaminophen-induced Hepatic-nephrotoxicity in Murine Model
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_51_Hepatitis C Elimination in Rwanda: The Case-Finding Journey
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_52_Rwanda’s journey to achieve low prices for Hepatitis C treatment drugs
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_53_Prevalence of Hepatitis among Select Key Populations in Botswana – Results of the 2nd Biological and Behavioral Surveillance Survey
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_54_Risk of residual transmission of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) through blood transfusion in Burkina Faso: preliminary results
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_55_Safety and efficacy of different direct-acting antiviral treatment regimens in hepatitis C infected patients with renal impairment: a single center experience
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_56_Assessment of protective serum anti-HBsAb levels among previously HBV vaccinated medical residents and its relation to duration and doses of vaccine – single center study
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_57_Infection chronique au virus de l’hépatite B (VHB) à antigène Hbe négatif au Sénégal : devenir des patients suivis à l’Hôpital Principal de Dakar
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_58_The Genedrive Assay Validation: A Point of Care Testing Device for Qualitative HCV RNA Detection
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_59_Epidemiology of Hepatitis B Virus Infection in Lubumbashi, Democratic Republic of Congo: Prevalence, risk factors and Genotype Distribution among Pregnant Women
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_60_Genotype distribution of hepatitis C virus: Experience in Maputo, Mozambique
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_61_Prevalence of Hepatitis B Virus and Vaccine Antibody Titers Among HIV Positive and Negative Infants in Botswana
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_62_Variceal Recurrence 4 years beyond Endoscopic Band Ligationin Hepatitis C Patients who Achieved Sustained Virological Response Post Direct Acting Antiviral Therapies.
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_63_Feasibility of the Public Health Approach in the Management of Hepatitis C Virus (HCV) in Nigeria, using the Pangenotypic Direct Acting Antiviral (DAAs)
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_64_Aetiology and outcomes of cirrhosis and hepatocellular carcinoma (HCC) in Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_66_Evaluation of the Efficacy of the Egyptian Program for Hepatitis B Virus Vaccination: A Cross Sectional National Survey
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_65_L’hépatite virale B chronique chez les patients porteurs de l’antigène HBe : aspects diagnostiques, thérapeutiques et évolutifs.
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_67_Performance of hepatitis B e antigen (HBeAg) rapid diagnostic tests (RDTs) in Malawi: A comparative evaluation in community and inpatient populations with hepatitis B virus (HBV)
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_68_Prevalence of hepatocellular carcinoma in Chronic Hepatitis B Genotype E African patients – a single centre experience
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_69_Assessment of Non-invasive Markers of Liver Fibrosis in Patients with Hepatitis C Virus in Ethiopia
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_70_Identifying Gaps Across the Cascade of Care for the Prevention of HBV Mother-To-Child Transmission in Burkina Faso: Findings from the Real World
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020